Brought to you by 
Genzyme, Sunway develop gene therapy
19 Nov 2007
Executive Summary
Genzyme and Sunway Biotech (oncolytic adenovirus therapies) will ally in the development, manufacturing, and commercialization in China of Ad2/HIF-1a, Genzyme's most advanced gene therapy candidate.
Deal Industry
- Biotechnology
- Pharmaceuticals
Deal Status
- Final
Deal Type
-
Alliance
- Intra-Biotech Deal
- R&D and Marketing (Licensing)
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com